HRP20190279T1 - Liječenje ovisnosti i poremećaja nagona pomoću pde7 inhibitora - Google Patents

Liječenje ovisnosti i poremećaja nagona pomoću pde7 inhibitora

Info

Publication number
HRP20190279T1
HRP20190279T1 HRP20190279TT HRP20190279T HRP20190279T1 HR P20190279 T1 HRP20190279 T1 HR P20190279T1 HR P20190279T T HRP20190279T T HR P20190279TT HR P20190279 T HRP20190279 T HR P20190279T HR P20190279 T1 HRP20190279 T1 HR P20190279T1
Authority
HR
Croatia
Prior art keywords
addiction
impulse
treatment
control disorders
pde7 inhibitors
Prior art date
Application number
HRP20190279TT
Other languages
English (en)
Inventor
Gregory A. Demopulos
George A. Gaitanaris
Roberto Ciccocioppo
Original Assignee
Omeros Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/835,607 external-priority patent/US9220715B2/en
Priority claimed from PCT/US2013/039866 external-priority patent/WO2013176877A2/en
Application filed by Omeros Corporation filed Critical Omeros Corporation
Publication of HRP20190279T1 publication Critical patent/HRP20190279T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HRP20190279TT 2012-05-07 2019-02-12 Liječenje ovisnosti i poremećaja nagona pomoću pde7 inhibitora HRP20190279T1 (hr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261643611P 2012-05-07 2012-05-07
US13/835,607 US9220715B2 (en) 2010-11-08 2013-03-15 Treatment of addiction and impulse-control disorders using PDE7 inhibitors
PCT/US2013/039866 WO2013176877A2 (en) 2012-05-07 2013-05-07 Treatment of addiction and impulse-control disorders using pde7 inhibitors
EP13793319.8A EP2846805B1 (en) 2012-05-07 2013-05-07 Treatment of addiction and impulse-control disorders using pde7 inhibitors

Publications (1)

Publication Number Publication Date
HRP20190279T1 true HRP20190279T1 (hr) 2019-04-05

Family

ID=55442549

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20190279TT HRP20190279T1 (hr) 2012-05-07 2019-02-12 Liječenje ovisnosti i poremećaja nagona pomoću pde7 inhibitora

Country Status (11)

Country Link
JP (4) JP2016138137A (hr)
CY (1) CY1121275T1 (hr)
DK (1) DK2846805T3 (hr)
ES (1) ES2711949T3 (hr)
HK (1) HK1208373A1 (hr)
HR (1) HRP20190279T1 (hr)
HU (1) HUE043518T2 (hr)
LT (1) LT2846805T (hr)
NZ (1) NZ628130A (hr)
PT (1) PT2846805T (hr)
RU (1) RU2665134C2 (hr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117836377A (zh) 2021-08-27 2024-04-05 住友金属矿山株式会社 红外线固化型油墨组合物、红外线固化物、红外线固化物的制造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10148233A1 (de) * 2001-09-28 2003-04-10 Boehringer Ingelheim Pharma Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme
PL1928438T3 (pl) * 2005-09-26 2013-08-30 Avigen Inc Zastosowanie ibudilastu do leczenia uzależnień od środków odurzających
CA2681650C (en) * 2007-03-27 2016-11-22 Omeros Corporation The use of pde7 inhibitors for the treatment of movement disorders
US8637528B2 (en) * 2007-03-27 2014-01-28 Omeros Corporation Use of PDE7 inhibitors for the treatment of movement disorders
EP3788877A1 (en) * 2007-04-11 2021-03-10 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions

Also Published As

Publication number Publication date
HUE043518T2 (hu) 2019-08-28
JP2021138766A (ja) 2021-09-16
JP2017171691A (ja) 2017-09-28
JP2019142980A (ja) 2019-08-29
PT2846805T (pt) 2019-02-27
RU2665134C2 (ru) 2018-08-28
RU2014149192A (ru) 2016-07-10
LT2846805T (lt) 2019-02-25
NZ628130A (en) 2017-02-24
CY1121275T1 (el) 2020-05-29
HK1208373A1 (en) 2016-03-04
JP6963431B2 (ja) 2021-11-10
ES2711949T3 (es) 2019-05-08
JP2016138137A (ja) 2016-08-04
DK2846805T3 (en) 2019-03-18

Similar Documents

Publication Publication Date Title
IL261768B (en) Devices and methods for tissue treatment
EP2640395A4 (en) TREATMENT OF DISEASES ASSOCIATED WITH SEARCH AND PULSE CONTROL BY PDE7 INHIBITORS
HRP20171352T1 (hr) Wnt-antagonisti i postupci liječenja
HK1205938A1 (en) Inhibitors of human ezh2, and methods of use thereof ezh2
EP2887805A4 (en) COMPOUNDS AND METHOD FOR TREATING BLOOD HIGH PRESSURE
SG11201504022RA (en) Glutamase inhibitors and method of use
HK1207968A1 (en) Usp30 inhibitors and methods of use usp30
EP2844271A4 (en) PROCESSING METHOD AND AGENTS USEFUL THEREFOR
GB201217296D0 (en) Method of treatment and/or prevention
IL280144A (en) Use of telomerase inhibitors to treat bone marrow culture disorders and bone marrow culture tumors
EP2852397A4 (en) HUWENTOXIN IV VARIANTS AND METHODS OF USE
EP2694079A4 (en) POLYMERS AND METHOD FOR PAIN TREATMENT
EP2825173A4 (en) CALMODULIN INHIBITORS FOR THE TREATMENT OF RIBOSOMAL DISEASES AND RIBOSOMAPATHIES
HK1206282A1 (en) Tfpi inhibitors and methods of use tfpi
ZA201501503B (en) Bio-inoculant and use thereof for treatment of effluents
ZA201408055B (en) Compositions and methods for the treatment of local pain
EP2846805A4 (en) TREATMENT OF SEARCH AND IMPULSE TROUBLESHOOTING BY PDE7 INHIBITORS
EP2681209A4 (en) COMPOUNDS AND METHODS FOR TREATING PAIN AND OTHER DISEASES
HRP20190279T1 (hr) Liječenje ovisnosti i poremećaja nagona pomoću pde7 inhibitora
EP2825184A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF PAIN
GB201101688D0 (en) Treatment of porous structire and device therefor